BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 22984531)

  • 1. Fasting enhances the response of glioma to chemo- and radiotherapy.
    Safdie F; Brandhorst S; Wei M; Wang W; Lee C; Hwang S; Conti PS; Chen TC; Longo VD
    PLoS One; 2012; 7(9):e44603. PubMed ID: 22984531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II trial of continuous dose-intense temozolomide in recurrent malignant glioma: RESCUE study.
    Perry JR; Bélanger K; Mason WP; Fulton D; Kavan P; Easaw J; Shields C; Kirby S; Macdonald DR; Eisenstat DD; Thiessen B; Forsyth P; Pouliot JF
    J Clin Oncol; 2010 Apr; 28(12):2051-7. PubMed ID: 20308655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temozolomide with radiation therapy in high grade brain gliomas: pharmaceuticals considerations and efficacy; a review article.
    Koukourakis GV; Kouloulias V; Zacharias G; Papadimitriou C; Pantelakos P; Maravelis G; Fotineas A; Beli I; Chaldeopoulos D; Kouvaris J
    Molecules; 2009 Apr; 14(4):1561-77. PubMed ID: 19384285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidermal growth factor receptor serum levels and prognostic value in malignant gliomas.
    Quaranta M; Divella R; Daniele A; Di Tardo S; Venneri MT; Lolli I; Troccoli G
    Tumori; 2007; 93(3):275-80. PubMed ID: 17679463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trans-sodium crocetinate enhancing survival and glioma response on magnetic resonance imaging to radiation and temozolomide.
    Sheehan J; Cifarelli CP; Dassoulas K; Olson C; Rainey J; Han S
    J Neurosurg; 2010 Aug; 113(2):234-9. PubMed ID: 20001586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temozolomide in radio-chemotherapy combined treatment for newly-diagnosed glioblastoma multiforme: phase II clinical trial.
    Lanzetta G; Campanella C; Rozzi A; Nappa M; Costa A; Fedele F; Innocenzi G; Gagliardi FM; Salvati M; Minniti G; Frati A; Frati L; Vecchione A
    Anticancer Res; 2003; 23(6D):5159-64. PubMed ID: 14981983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythropoietin augments survival of glioma cells after radiation and temozolomide.
    Hassouna I; Sperling S; Kim E; Schulz-Schaeffer W; Rave-Fränk M; Hasselblatt M; Jelkmann W; Giese A; Ehrenreich H
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):927-34. PubMed ID: 19014782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temozolomide and treatment of malignant glioma.
    Friedman HS; Kerby T; Calvert H
    Clin Cancer Res; 2000 Jul; 6(7):2585-97. PubMed ID: 10914698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temozolomide in early stages of newly diagnosed malignant glioma and neoplastic meningitis.
    Friedman HS
    Semin Oncol; 2000 Jun; 27(3 Suppl 6):35-40. PubMed ID: 10866348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The PI3K inhibitor GDC-0941 enhances radiosensitization and reduces chemoresistance to temozolomide in GBM cell lines.
    Shi F; Guo H; Zhang R; Liu H; Wu L; Wu Q; Liu J; Liu T; Zhang Q
    Neuroscience; 2017 Mar; 346():298-308. PubMed ID: 28147244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulated Electrohyperthermia in Integrative Cancer Treatment for Relapsed Malignant Glioblastoma and Astrocytoma: Retrospective Multicenter Controlled Study.
    Fiorentini G; Sarti D; Milandri C; Dentico P; Mambrini A; Fiorentini C; Mattioli G; Casadei V; Guadagni S
    Integr Cancer Ther; 2019; 18():1534735418812691. PubMed ID: 30580645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of the HSP90 inhibitor 17-AAG in human glioma cell lines and tumorigenic glioma stem cells.
    Sauvageot CM; Weatherbee JL; Kesari S; Winters SE; Barnes J; Dellagatta J; Ramakrishna NR; Stiles CD; Kung AL; Kieran MW; Wen PY
    Neuro Oncol; 2009 Apr; 11(2):109-21. PubMed ID: 18682579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-grade gliomas: results in patients treated with adjuvant radiotherapy alone and with adjuvant radio-chemotherapy.
    Valeriani M; Ferretti A; Franzese P; Tombolini V
    Anticancer Res; 2006; 26(3B):2429-35. PubMed ID: 16821628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temozolomide after radiotherapy for newly diagnosed high-grade glioma and unfavorable low-grade glioma in children.
    Broniscer A; Chintagumpala M; Fouladi M; Krasin MJ; Kocak M; Bowers DC; Iacono LC; Merchant TE; Stewart CF; Houghton PJ; Kun LE; Ledet D; Gajjar A
    J Neurooncol; 2006 Feb; 76(3):313-9. PubMed ID: 16200343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term calorie and protein restriction provide partial protection from chemotoxicity but do not delay glioma progression.
    Brandhorst S; Wei M; Hwang S; Morgan TE; Longo VD
    Exp Gerontol; 2013 Oct; 48(10):1120-8. PubMed ID: 23454633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiation combined with temozolomide contraindicated for young adults diagnosed with anaplastic glioma.
    Yang P; Zhang C; Cai J; You G; Wang Y; Qiu X; Li S; Wu C; Yao K; Li W; Peng X; Zhang W; Jiang T
    Oncotarget; 2016 Nov; 7(48):80091-80100. PubMed ID: 27590514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First-line treatment of malignant glioma with carmustine implants followed by concomitant radiochemotherapy: a multicenter experience.
    Bock HC; Puchner MJ; Lohmann F; Schütze M; Koll S; Ketter R; Buchalla R; Rainov N; Kantelhardt SR; Rohde V; Giese A
    Neurosurg Rev; 2010 Oct; 33(4):441-9. PubMed ID: 20706757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic impact of hemoglobin level and other factors in patients with high-grade gliomas treated with postoperative radiochemotherapy and sequential chemotherapy based on temozolomide: a 10-year experience at a single institution.
    Céfaro GA; Genovesi D; Vinciguerra A; Trignani M; Taraborrelli M; Augurio A; Buonaguidi R; Galzio RJ; Di Nicola M
    Strahlenther Onkol; 2011 Dec; 187(12):778-83. PubMed ID: 22127356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Glioma therapy up-date].
    de la Fuente BP; Dalmau J; Rosenfeld M
    Neurologia; 2007 Apr; 22(3):159-69. PubMed ID: 17364254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic antitumor effect with indoleamine 2,3-dioxygenase inhibition and temozolomide in a murine glioma model.
    Hanihara M; Kawataki T; Oh-Oka K; Mitsuka K; Nakao A; Kinouchi H
    J Neurosurg; 2016 Jun; 124(6):1594-601. PubMed ID: 26636389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.